nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP1A2—type 2 diabetes mellitus	0.178	0.602	CbGaD
Domperidone—CYP3A4—type 2 diabetes mellitus	0.118	0.398	CbGaD
Domperidone—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0422	0.0815	CbGbCtD
Domperidone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0282	0.0544	CbGbCtD
Domperidone—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0247	0.0477	CbGbCtD
Domperidone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0225	0.0435	CbGbCtD
Domperidone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0214	0.0413	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0214	0.0413	CbGbCtD
Domperidone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0214	0.0413	CbGbCtD
Domperidone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0204	0.0393	CbGbCtD
Domperidone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0191	0.0368	CbGbCtD
Domperidone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0188	0.0363	CbGbCtD
Domperidone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0182	0.0351	CbGbCtD
Domperidone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0161	0.031	CbGbCtD
Domperidone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0148	0.0286	CbGbCtD
Domperidone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0146	0.0281	CbGbCtD
Domperidone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0138	0.0266	CbGbCtD
Domperidone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.013	0.0251	CbGbCtD
Domperidone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0128	0.0248	CbGbCtD
Domperidone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.012	0.0232	CbGbCtD
Domperidone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0115	0.0221	CbGbCtD
Domperidone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0114	0.0221	CbGbCtD
Domperidone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0108	0.0209	CbGbCtD
Domperidone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0105	0.0202	CbGbCtD
Domperidone—CYP3A5—Losartan—type 2 diabetes mellitus	0.00993	0.0192	CbGbCtD
Domperidone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00985	0.019	CbGbCtD
Domperidone—CYP2C8—Losartan—type 2 diabetes mellitus	0.00954	0.0184	CbGbCtD
Domperidone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00948	0.0183	CbGbCtD
Domperidone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00945	0.0182	CbGbCtD
Domperidone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00914	0.0176	CbGbCtD
Domperidone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00827	0.016	CbGbCtD
Domperidone—CYP1A2—Losartan—type 2 diabetes mellitus	0.00739	0.0143	CbGbCtD
Domperidone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00706	0.0136	CbGbCtD
Domperidone—ABCB1—Losartan—type 2 diabetes mellitus	0.00646	0.0125	CbGbCtD
Domperidone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00626	0.0121	CbGbCtD
Domperidone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00601	0.0116	CbGbCtD
Domperidone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00601	0.0116	CbGbCtD
Domperidone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00568	0.011	CbGbCtD
Domperidone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00423	0.00817	CbGbCtD
Domperidone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00387	0.00747	CbGbCtD
Domperidone—Pimozide—CALM1—type 2 diabetes mellitus	0.000429	0.108	CrCbGaD
Domperidone—Insomnia—Glipizide—type 2 diabetes mellitus	0.000339	0.00292	CcSEcCtD
Domperidone—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000335	0.00289	CcSEcCtD
Domperidone—Nausea—Tolazamide—type 2 diabetes mellitus	0.000335	0.00289	CcSEcCtD
Domperidone—Somnolence—Glipizide—type 2 diabetes mellitus	0.000333	0.00287	CcSEcCtD
Domperidone—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000333	0.00287	CcSEcCtD
Domperidone—Rash—Nateglinide—type 2 diabetes mellitus	0.00033	0.00284	CcSEcCtD
Domperidone—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.00033	0.00284	CcSEcCtD
Domperidone—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000329	0.00284	CcSEcCtD
Domperidone—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000327	0.00282	CcSEcCtD
Domperidone—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000325	0.00281	CcSEcCtD
Domperidone—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000325	0.0028	CcSEcCtD
Domperidone—Nausea—Acarbose—type 2 diabetes mellitus	0.000322	0.00278	CcSEcCtD
Domperidone—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000322	0.00277	CcSEcCtD
Domperidone—Constipation—Glipizide—type 2 diabetes mellitus	0.00032	0.00276	CcSEcCtD
Domperidone—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00032	0.00276	CcSEcCtD
Domperidone—Sertindole—ADRA2A—type 2 diabetes mellitus	0.000319	0.0799	CrCbGaD
Domperidone—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000316	0.00273	CcSEcCtD
Domperidone—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000315	0.00272	CcSEcCtD
Domperidone—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000315	0.00272	CcSEcCtD
Domperidone—Pollakiuria—Losartan—type 2 diabetes mellitus	0.000312	0.00269	CcSEcCtD
Domperidone—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.000311	0.00268	CcSEcCtD
Domperidone—Tension—Gliclazide—type 2 diabetes mellitus	0.000311	0.00268	CcSEcCtD
Domperidone—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000311	0.00268	CcSEcCtD
Domperidone—Nausea—Nateglinide—type 2 diabetes mellitus	0.000311	0.00268	CcSEcCtD
Domperidone—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00031	0.00267	CcSEcCtD
Domperidone—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00031	0.00267	CcSEcCtD
Domperidone—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000308	0.00266	CcSEcCtD
Domperidone—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000308	0.00265	CcSEcCtD
Domperidone—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000307	0.00265	CcSEcCtD
Domperidone—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000307	0.00264	CcSEcCtD
Domperidone—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000303	0.00261	CcSEcCtD
Domperidone—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000298	0.00257	CcSEcCtD
Domperidone—Urticaria—Glipizide—type 2 diabetes mellitus	0.000298	0.00256	CcSEcCtD
Domperidone—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000296	0.00255	CcSEcCtD
Domperidone—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000295	0.00254	CcSEcCtD
Domperidone—Sertindole—HTR2C—type 2 diabetes mellitus	0.000293	0.0735	CrCbGaD
Domperidone—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000293	0.00253	CcSEcCtD
Domperidone—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000293	0.00252	CcSEcCtD
Domperidone—Oedema—Glyburide—type 2 diabetes mellitus	0.000288	0.00248	CcSEcCtD
Domperidone—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000288	0.00248	CcSEcCtD
Domperidone—Rash—Repaglinide—type 2 diabetes mellitus	0.000285	0.00246	CcSEcCtD
Domperidone—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000285	0.00246	CcSEcCtD
Domperidone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000285	0.00246	CcSEcCtD
Domperidone—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000285	0.00246	CcSEcCtD
Domperidone—Headache—Repaglinide—type 2 diabetes mellitus	0.000284	0.00244	CcSEcCtD
Domperidone—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000283	0.00244	CcSEcCtD
Domperidone—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00028	0.00242	CcSEcCtD
Domperidone—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00028	0.00242	CcSEcCtD
Domperidone—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.00028	0.00241	CcSEcCtD
Domperidone—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000278	0.00239	CcSEcCtD
Domperidone—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000278	0.00239	CcSEcCtD
Domperidone—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000277	0.00239	CcSEcCtD
Domperidone—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000277	0.00239	CcSEcCtD
Domperidone—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000276	0.00238	CcSEcCtD
Domperidone—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000275	0.00237	CcSEcCtD
Domperidone—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000271	0.0679	CrCbGaD
Domperidone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00027	0.00233	CcSEcCtD
Domperidone—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00027	0.00232	CcSEcCtD
Domperidone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00232	CcSEcCtD
Domperidone—Hypotension—Glyburide—type 2 diabetes mellitus	0.000269	0.00232	CcSEcCtD
Domperidone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000269	0.00232	CcSEcCtD
Domperidone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000269	0.00232	CcSEcCtD
Domperidone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000268	0.00231	CcSEcCtD
Domperidone—Pruritus—Glipizide—type 2 diabetes mellitus	0.000265	0.00228	CcSEcCtD
Domperidone—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000264	0.00228	CcSEcCtD
Domperidone—Palpitations—Valsartan—type 2 diabetes mellitus	0.000257	0.00222	CcSEcCtD
Domperidone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000257	0.00222	CcSEcCtD
Domperidone—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000257	0.00222	CcSEcCtD
Domperidone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000256	0.00221	CcSEcCtD
Domperidone—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000255	0.0022	CcSEcCtD
Domperidone—Palpitations—Orlistat—type 2 diabetes mellitus	0.000254	0.00219	CcSEcCtD
Domperidone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000254	0.00219	CcSEcCtD
Domperidone—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000254	0.00219	CcSEcCtD
Domperidone—Perphenazine—CALM1—type 2 diabetes mellitus	0.000253	0.0634	CrCbGaD
Domperidone—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000252	0.00217	CcSEcCtD
Domperidone—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000251	0.00217	CcSEcCtD
Domperidone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000251	0.00216	CcSEcCtD
Domperidone—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00216	CcSEcCtD
Domperidone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00025	0.00215	CcSEcCtD
Domperidone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000249	0.00215	CcSEcCtD
Domperidone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000248	0.00214	CcSEcCtD
Domperidone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000247	0.00213	CcSEcCtD
Domperidone—Tension—Irbesartan—type 2 diabetes mellitus	0.000246	0.00212	CcSEcCtD
Domperidone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000245	0.00212	CcSEcCtD
Domperidone—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000243	0.0021	CcSEcCtD
Domperidone—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000243	0.00209	CcSEcCtD
Domperidone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000242	0.00208	CcSEcCtD
Domperidone—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000242	0.00208	CcSEcCtD
Domperidone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000241	0.00208	CcSEcCtD
Domperidone—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00024	0.00207	CcSEcCtD
Domperidone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000239	0.00206	CcSEcCtD
Domperidone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00206	CcSEcCtD
Domperidone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000238	0.00205	CcSEcCtD
Domperidone—Oedema—Valsartan—type 2 diabetes mellitus	0.000238	0.00205	CcSEcCtD
Domperidone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000237	0.00205	CcSEcCtD
Domperidone—Rash—Glipizide—type 2 diabetes mellitus	0.000236	0.00204	CcSEcCtD
Domperidone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000236	0.00203	CcSEcCtD
Domperidone—Oedema—Orlistat—type 2 diabetes mellitus	0.000235	0.00203	CcSEcCtD
Domperidone—Headache—Glipizide—type 2 diabetes mellitus	0.000235	0.00202	CcSEcCtD
Domperidone—Palpitations—Metformin—type 2 diabetes mellitus	0.000234	0.00202	CcSEcCtD
Domperidone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000234	0.00202	CcSEcCtD
Domperidone—Tension—Losartan—type 2 diabetes mellitus	0.000231	0.00199	CcSEcCtD
Domperidone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000231	0.00199	CcSEcCtD
Domperidone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00023	0.00199	CcSEcCtD
Domperidone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00023	0.00198	CcSEcCtD
Domperidone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000229	0.00197	CcSEcCtD
Domperidone—Nervousness—Losartan—type 2 diabetes mellitus	0.000229	0.00197	CcSEcCtD
Domperidone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000228	0.00196	CcSEcCtD
Domperidone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000228	0.00196	CcSEcCtD
Domperidone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000227	0.00195	CcSEcCtD
Domperidone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000226	0.00195	CcSEcCtD
Domperidone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000225	0.00194	CcSEcCtD
Domperidone—Nausea—Glipizide—type 2 diabetes mellitus	0.000222	0.00192	CcSEcCtD
Domperidone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000222	0.00192	CcSEcCtD
Domperidone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000222	0.00192	CcSEcCtD
Domperidone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00191	CcSEcCtD
Domperidone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000221	0.00191	CcSEcCtD
Domperidone—Rash—Glimepiride—type 2 diabetes mellitus	0.00022	0.0019	CcSEcCtD
Domperidone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00022	0.0019	CcSEcCtD
Domperidone—Rash—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00189	CcSEcCtD
Domperidone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00189	CcSEcCtD
Domperidone—Headache—Glimepiride—type 2 diabetes mellitus	0.000219	0.00189	CcSEcCtD
Domperidone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000218	0.00188	CcSEcCtD
Domperidone—Oedema—Metformin—type 2 diabetes mellitus	0.000217	0.00187	CcSEcCtD
Domperidone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00186	CcSEcCtD
Domperidone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000215	0.00185	CcSEcCtD
Domperidone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000213	0.00183	CcSEcCtD
Domperidone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000211	0.00182	CcSEcCtD
Domperidone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000209	0.0018	CcSEcCtD
Domperidone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000208	0.0018	CcSEcCtD
Domperidone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000208	0.0018	CcSEcCtD
Domperidone—Palpitations—Losartan—type 2 diabetes mellitus	0.000208	0.0018	CcSEcCtD
Domperidone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000208	0.00179	CcSEcCtD
Domperidone—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000207	0.00179	CcSEcCtD
Domperidone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000207	0.00178	CcSEcCtD
Domperidone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000207	0.00178	CcSEcCtD
Domperidone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000207	0.00178	CcSEcCtD
Domperidone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000206	0.00177	CcSEcCtD
Domperidone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000205	0.00176	CcSEcCtD
Domperidone—Oedema—Irbesartan—type 2 diabetes mellitus	0.000204	0.00176	CcSEcCtD
Domperidone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000204	0.00176	CcSEcCtD
Domperidone—Constipation—Valsartan—type 2 diabetes mellitus	0.000203	0.00175	CcSEcCtD
Domperidone—Hypotension—Metformin—type 2 diabetes mellitus	0.000202	0.00174	CcSEcCtD
Domperidone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00173	CcSEcCtD
Domperidone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00171	CcSEcCtD
Domperidone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00171	CcSEcCtD
Domperidone—Tension—Ramipril—type 2 diabetes mellitus	0.000198	0.00171	CcSEcCtD
Domperidone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000198	0.0017	CcSEcCtD
Domperidone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000197	0.0017	CcSEcCtD
Domperidone—Nervousness—Ramipril—type 2 diabetes mellitus	0.000196	0.00169	CcSEcCtD
Domperidone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000196	0.00169	CcSEcCtD
Domperidone—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000194	0.00167	CcSEcCtD
Domperidone—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	0.000194	0.0487	CrCbGaD
Domperidone—Nefazodone—ADRA2A—type 2 diabetes mellitus	0.000193	0.0484	CrCbGaD
Domperidone—Somnolence—Metformin—type 2 diabetes mellitus	0.000193	0.00166	CcSEcCtD
Domperidone—Oedema—Losartan—type 2 diabetes mellitus	0.000192	0.00166	CcSEcCtD
Domperidone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000191	0.00165	CcSEcCtD
Domperidone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000191	0.00164	CcSEcCtD
Domperidone—Urticaria—Valsartan—type 2 diabetes mellitus	0.000189	0.00163	CcSEcCtD
Domperidone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Domperidone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00161	CcSEcCtD
Domperidone—Urticaria—Orlistat—type 2 diabetes mellitus	0.000187	0.00161	CcSEcCtD
Domperidone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000186	0.0016	CcSEcCtD
Domperidone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000186	0.0016	CcSEcCtD
Domperidone—Constipation—Metformin—type 2 diabetes mellitus	0.000185	0.0016	CcSEcCtD
Domperidone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000183	0.00158	CcSEcCtD
Domperidone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000183	0.00158	CcSEcCtD
Domperidone—Rash—Glyburide—type 2 diabetes mellitus	0.000182	0.00157	CcSEcCtD
Domperidone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000182	0.00157	CcSEcCtD
Domperidone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000182	0.00157	CcSEcCtD
Domperidone—Headache—Glyburide—type 2 diabetes mellitus	0.000181	0.00156	CcSEcCtD
Domperidone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00018	0.00155	CcSEcCtD
Domperidone—Hypotension—Losartan—type 2 diabetes mellitus	0.00018	0.00155	CcSEcCtD
Domperidone—Trazodone—ADRA2A—type 2 diabetes mellitus	0.000179	0.0448	CrCbGaD
Domperidone—Palpitations—Ramipril—type 2 diabetes mellitus	0.000179	0.00154	CcSEcCtD
Domperidone—Nefazodone—HTR2C—type 2 diabetes mellitus	0.000178	0.0446	CrCbGaD
Domperidone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000177	0.00153	CcSEcCtD
Domperidone—Constipation—Irbesartan—type 2 diabetes mellitus	0.000175	0.00151	CcSEcCtD
Domperidone—Insomnia—Losartan—type 2 diabetes mellitus	0.000174	0.0015	CcSEcCtD
Domperidone—Urticaria—Metformin—type 2 diabetes mellitus	0.000172	0.00148	CcSEcCtD
Domperidone—Nausea—Glyburide—type 2 diabetes mellitus	0.000171	0.00148	CcSEcCtD
Domperidone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000171	0.00148	CcSEcCtD
Domperidone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000171	0.00148	CcSEcCtD
Domperidone—Somnolence—Losartan—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Domperidone—Asthenia—Valsartan—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Domperidone—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000169	0.00146	CcSEcCtD
Domperidone—Asthenia—Orlistat—type 2 diabetes mellitus	0.000169	0.00145	CcSEcCtD
Domperidone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000168	0.00145	CcSEcCtD
Domperidone—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000168	0.00145	CcSEcCtD
Domperidone—Pruritus—Orlistat—type 2 diabetes mellitus	0.000166	0.00143	CcSEcCtD
Domperidone—Oedema—Ramipril—type 2 diabetes mellitus	0.000165	0.00142	CcSEcCtD
Domperidone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000165	0.00142	CcSEcCtD
Domperidone—Constipation—Losartan—type 2 diabetes mellitus	0.000164	0.00142	CcSEcCtD
Domperidone—Trazodone—HTR2C—type 2 diabetes mellitus	0.000164	0.0412	CrCbGaD
Domperidone—Rash—Gliclazide—type 2 diabetes mellitus	0.000163	0.00141	CcSEcCtD
Domperidone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000163	0.00141	CcSEcCtD
Domperidone—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000163	0.0014	CcSEcCtD
Domperidone—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000162	0.0014	CcSEcCtD
Domperidone—Headache—Gliclazide—type 2 diabetes mellitus	0.000162	0.0014	CcSEcCtD
Domperidone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000162	0.00139	CcSEcCtD
Domperidone—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000161	0.00139	CcSEcCtD
Domperidone—Dizziness—Valsartan—type 2 diabetes mellitus	0.000157	0.00136	CcSEcCtD
Domperidone—Dizziness—Orlistat—type 2 diabetes mellitus	0.000155	0.00134	CcSEcCtD
Domperidone—Asthenia—Metformin—type 2 diabetes mellitus	0.000155	0.00134	CcSEcCtD
Domperidone—Hypotension—Ramipril—type 2 diabetes mellitus	0.000154	0.00133	CcSEcCtD
Domperidone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000154	0.00133	CcSEcCtD
Domperidone—Pruritus—Metformin—type 2 diabetes mellitus	0.000153	0.00132	CcSEcCtD
Domperidone—Urticaria—Losartan—type 2 diabetes mellitus	0.000153	0.00132	CcSEcCtD
Domperidone—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000152	0.00131	CcSEcCtD
Domperidone—Vomiting—Valsartan—type 2 diabetes mellitus	0.000151	0.0013	CcSEcCtD
Domperidone—Rash—Valsartan—type 2 diabetes mellitus	0.00015	0.00129	CcSEcCtD
Domperidone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00015	0.00129	CcSEcCtD
Domperidone—Vomiting—Orlistat—type 2 diabetes mellitus	0.000149	0.00129	CcSEcCtD
Domperidone—Insomnia—Ramipril—type 2 diabetes mellitus	0.000149	0.00129	CcSEcCtD
Domperidone—Headache—Valsartan—type 2 diabetes mellitus	0.000149	0.00128	CcSEcCtD
Domperidone—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000148	0.00128	CcSEcCtD
Domperidone—Rash—Orlistat—type 2 diabetes mellitus	0.000148	0.00128	CcSEcCtD
Domperidone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000148	0.00128	CcSEcCtD
Domperidone—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000147	0.0369	CrCbGaD
Domperidone—Headache—Orlistat—type 2 diabetes mellitus	0.000147	0.00127	CcSEcCtD
Domperidone—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000147	0.00126	CcSEcCtD
Domperidone—Somnolence—Ramipril—type 2 diabetes mellitus	0.000147	0.00126	CcSEcCtD
Domperidone—Sertindole—CYP3A4—type 2 diabetes mellitus	0.000147	0.0367	CrCbGaD
Domperidone—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000145	0.00125	CcSEcCtD
Domperidone—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000145	0.00125	CcSEcCtD
Domperidone—Dizziness—Metformin—type 2 diabetes mellitus	0.000143	0.00123	CcSEcCtD
Domperidone—Pimozide—CYP2E1—type 2 diabetes mellitus	0.000142	0.0355	CrCbGaD
Domperidone—Nausea—Valsartan—type 2 diabetes mellitus	0.000141	0.00122	CcSEcCtD
Domperidone—Constipation—Ramipril—type 2 diabetes mellitus	0.000141	0.00122	CcSEcCtD
Domperidone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00014	0.00121	CcSEcCtD
Domperidone—Nausea—Orlistat—type 2 diabetes mellitus	0.00014	0.0012	CcSEcCtD
Domperidone—Asthenia—Losartan—type 2 diabetes mellitus	0.000138	0.00119	CcSEcCtD
Domperidone—Vomiting—Metformin—type 2 diabetes mellitus	0.000138	0.00119	CcSEcCtD
Domperidone—Rash—Metformin—type 2 diabetes mellitus	0.000137	0.00118	CcSEcCtD
Domperidone—Dermatitis—Metformin—type 2 diabetes mellitus	0.000136	0.00118	CcSEcCtD
Domperidone—Pruritus—Losartan—type 2 diabetes mellitus	0.000136	0.00117	CcSEcCtD
Domperidone—Headache—Metformin—type 2 diabetes mellitus	0.000136	0.00117	CcSEcCtD
Domperidone—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000135	0.00116	CcSEcCtD
Domperidone—Pimozide—CYP1A2—type 2 diabetes mellitus	0.000135	0.0338	CrCbGaD
Domperidone—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000132	0.00113	CcSEcCtD
Domperidone—Urticaria—Ramipril—type 2 diabetes mellitus	0.000131	0.00113	CcSEcCtD
Domperidone—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00013	0.00112	CcSEcCtD
Domperidone—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00013	0.00112	CcSEcCtD
Domperidone—Rash—Irbesartan—type 2 diabetes mellitus	0.000129	0.00111	CcSEcCtD
Domperidone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000129	0.00111	CcSEcCtD
Domperidone—Nausea—Metformin—type 2 diabetes mellitus	0.000129	0.00111	CcSEcCtD
Domperidone—Headache—Irbesartan—type 2 diabetes mellitus	0.000128	0.0011	CcSEcCtD
Domperidone—Dizziness—Losartan—type 2 diabetes mellitus	0.000127	0.0011	CcSEcCtD
Domperidone—Vomiting—Losartan—type 2 diabetes mellitus	0.000122	0.00105	CcSEcCtD
Domperidone—Nausea—Irbesartan—type 2 diabetes mellitus	0.000121	0.00105	CcSEcCtD
Domperidone—Rash—Losartan—type 2 diabetes mellitus	0.000121	0.00105	CcSEcCtD
Domperidone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000121	0.00104	CcSEcCtD
Domperidone—Headache—Losartan—type 2 diabetes mellitus	0.00012	0.00104	CcSEcCtD
Domperidone—Asthenia—Ramipril—type 2 diabetes mellitus	0.000118	0.00102	CcSEcCtD
Domperidone—Pruritus—Ramipril—type 2 diabetes mellitus	0.000117	0.00101	CcSEcCtD
Domperidone—Pipotiazine—CYP1A2—type 2 diabetes mellitus	0.000116	0.0291	CrCbGaD
Domperidone—Perphenazine—ADRA2A—type 2 diabetes mellitus	0.000114	0.0287	CrCbGaD
Domperidone—Nausea—Losartan—type 2 diabetes mellitus	0.000114	0.000985	CcSEcCtD
Domperidone—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000113	0.000973	CcSEcCtD
Domperidone—Dizziness—Ramipril—type 2 diabetes mellitus	0.000109	0.00094	CcSEcCtD
Domperidone—Perphenazine—HTR2C—type 2 diabetes mellitus	0.000105	0.0264	CrCbGaD
Domperidone—Vomiting—Ramipril—type 2 diabetes mellitus	0.000105	0.000904	CcSEcCtD
Domperidone—Rash—Ramipril—type 2 diabetes mellitus	0.000104	0.000896	CcSEcCtD
Domperidone—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000104	0.000896	CcSEcCtD
Domperidone—Headache—Ramipril—type 2 diabetes mellitus	0.000103	0.000891	CcSEcCtD
Domperidone—Nausea—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000844	CcSEcCtD
Domperidone—Pimozide—CYP3A4—type 2 diabetes mellitus	8.93e-05	0.0224	CrCbGaD
Domperidone—Nefazodone—CYP3A4—type 2 diabetes mellitus	8.88e-05	0.0223	CrCbGaD
Domperidone—Trazodone—CYP3A4—type 2 diabetes mellitus	8.21e-05	0.0206	CrCbGaD
Domperidone—Perphenazine—CYP1A2—type 2 diabetes mellitus	7.94e-05	0.0199	CrCbGaD
Domperidone—Pipotiazine—CYP3A4—type 2 diabetes mellitus	7.7e-05	0.0193	CrCbGaD
Domperidone—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	7.35e-05	0.0184	CrCbGaD
Domperidone—Pipotiazine—ALB—type 2 diabetes mellitus	6.71e-05	0.0168	CrCbGaD
Domperidone—Perphenazine—CYP3A4—type 2 diabetes mellitus	5.26e-05	0.0132	CrCbGaD
Domperidone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.65e-06	7.01e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—INS—type 2 diabetes mellitus	4.64e-06	7e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.63e-06	6.99e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.63e-06	6.98e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.63e-06	6.98e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.62e-06	6.97e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.61e-06	6.95e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.6e-06	6.93e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.6e-06	6.93e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.57e-06	6.89e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.57e-06	6.88e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.56e-06	6.88e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.54e-06	6.85e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.49e-06	6.77e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.48e-06	6.76e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.48e-06	6.76e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	4.48e-06	6.76e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.47e-06	6.74e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.47e-06	6.73e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	4.46e-06	6.73e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.42e-06	6.66e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.41e-06	6.65e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.41e-06	6.65e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.41e-06	6.65e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	4.4e-06	6.63e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.38e-06	6.61e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.32e-06	6.51e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.31e-06	6.5e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.31e-06	6.5e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.31e-06	6.5e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.3e-06	6.48e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.29e-06	6.47e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.26e-06	6.43e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.26e-06	6.42e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.26e-06	6.42e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.25e-06	6.4e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.24e-06	6.4e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.23e-06	6.38e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.23e-06	6.37e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.23e-06	6.37e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.21e-06	6.35e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.19e-06	6.32e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.19e-06	6.31e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.17e-06	6.29e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.17e-06	6.29e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.16e-06	6.28e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.16e-06	6.27e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.16e-06	6.27e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.16e-06	6.27e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.13e-06	6.23e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.12e-06	6.22e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.12e-06	6.22e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.11e-06	6.2e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.11e-06	6.2e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.1e-06	6.18e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.09e-06	6.17e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.08e-06	6.15e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.07e-06	6.14e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.07e-06	6.14e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.03e-06	6.08e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.03e-06	6.08e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.03e-06	6.08e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.01e-06	6.05e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4e-06	6.04e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.96e-06	5.97e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.95e-06	5.96e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.94e-06	5.94e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.92e-06	5.91e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.89e-06	5.87e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.88e-06	5.85e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.86e-06	5.83e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.84e-06	5.8e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.83e-06	5.78e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.8e-06	5.73e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.8e-06	5.73e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.8e-06	5.73e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.8e-06	5.73e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.8e-06	5.73e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.79e-06	5.72e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.78e-06	5.7e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.78e-06	5.7e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.74e-06	5.64e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.73e-06	5.63e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.73e-06	5.63e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.73e-06	5.63e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.73e-06	5.62e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.72e-06	5.61e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.71e-06	5.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.71e-06	5.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.71e-06	5.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.71e-06	5.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.68e-06	5.55e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.67e-06	5.54e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.63e-06	5.48e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.62e-06	5.46e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.62e-06	5.45e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.6e-06	5.44e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.59e-06	5.42e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.58e-06	5.4e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.58e-06	5.39e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.56e-06	5.37e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.55e-06	5.36e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	3.55e-06	5.35e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.54e-06	5.34e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.53e-06	5.33e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.52e-06	5.31e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.49e-06	5.27e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.49e-06	5.26e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.49e-06	5.26e-05	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.49e-06	5.26e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.48e-06	5.25e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.46e-06	5.22e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.45e-06	5.21e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.44e-06	5.19e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.43e-06	5.18e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.43e-06	5.18e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.43e-06	5.18e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.42e-06	5.15e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.39e-06	5.11e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.37e-06	5.09e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.32e-06	5.01e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.32e-06	5.01e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.32e-06	5.01e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.3e-06	4.98e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.29e-06	4.96e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.27e-06	4.93e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.26e-06	4.92e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.26e-06	4.92e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.26e-06	4.92e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.25e-06	4.89e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.24e-06	4.89e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.23e-06	4.88e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.23e-06	4.87e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.22e-06	4.85e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.22e-06	4.85e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-06	4.83e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.19e-06	4.82e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.17e-06	4.78e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.16e-06	4.77e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.16e-06	4.77e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.14e-06	4.74e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.13e-06	4.71e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.13e-06	4.71e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.11e-06	4.7e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.11e-06	4.7e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.11e-06	4.7e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.09e-06	4.66e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.08e-06	4.64e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-06	4.64e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.07e-06	4.63e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-06	4.61e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.05e-06	4.61e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.05e-06	4.61e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.04e-06	4.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.04e-06	4.58e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.02e-06	4.55e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.01e-06	4.54e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.01e-06	4.53e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.01e-06	4.53e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.99e-06	4.5e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	4.46e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.93e-06	4.42e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.93e-06	4.42e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.93e-06	4.42e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-06	4.39e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	4.37e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.88e-06	4.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.88e-06	4.35e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.87e-06	4.33e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	4.32e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.86e-06	4.31e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.86e-06	4.31e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.79e-06	4.21e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.78e-06	4.2e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.77e-06	4.17e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.75e-06	4.15e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.69e-06	4.06e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.68e-06	4.04e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.67e-06	4.02e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-06	3.99e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-06	3.99e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.64e-06	3.99e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.64e-06	3.98e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.64e-06	3.98e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.63e-06	3.96e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.63e-06	3.96e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.59e-06	3.9e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	3.81e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.51e-06	3.78e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.5e-06	3.77e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.48e-06	3.75e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.48e-06	3.75e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	3.74e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.47e-06	3.73e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.47e-06	3.73e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-06	3.72e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.46e-06	3.7e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.44e-06	3.68e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.43e-06	3.66e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.42e-06	3.65e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.42e-06	3.65e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.41e-06	3.63e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.37e-06	3.57e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	3.48e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	3.48e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.3e-06	3.47e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.3e-06	3.47e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	3.42e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.26e-06	3.41e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.24e-06	3.38e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.21e-06	3.34e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.21e-06	3.33e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-06	3.28e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-06	3.28e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.15e-06	3.24e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-06	3.23e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.12e-06	3.2e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.11e-06	3.18e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.1e-06	3.16e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.06e-06	3.11e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.04e-06	3.07e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.03e-06	3.06e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.02e-06	3.04e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2e-06	3.01e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	3e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.94e-06	2.93e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.93e-06	2.92e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	2.9e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.9e-06	2.87e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.9e-06	2.86e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.87e-06	2.83e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.87e-06	2.82e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	2.78e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	2.78e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	2.54e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.65e-06	2.49e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.62e-06	2.44e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.55e-06	2.34e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.48e-06	2.24e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-06	2.17e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.43e-06	2.16e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.42e-06	2.14e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.42e-06	2.14e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.4e-06	2.12e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.3e-06	1.96e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	1.83e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	1.6e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.98e-07	1.51e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.46e-07	1.28e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.53e-07	9.84e-06	CbGpPWpGaD
